Cognitive Performance & TBI Recovery
Blast-related mild traumatic brain injury is the signature wound of post-9/11 SOF operations. Chronic post-concussion syndrome degrades executive function, attention, processing speed, and memory, directly impairing operational decision-making. The following studies demonstrate HBOT’s proven capacity to induce neuroplasticity, restore cerebral blood flow, and deliver measurable cognitive improvements in military and civilian TBI populations.
Boussi-Gross R, Golan H, Fishlev G, et al. (2013). PLoS ONE (194 citations)
Randomized prospective trial with crossover design (n=56 mTBI patients, 1–5 years post-injury). 40 HBOT sessions at 1.5 ATA produced significant improvements in cognitive function and quality of life, confirmed by SPECT imaging showing elevated brain activity. No improvement occurred during the control period. HBOT induced neuroplasticity and repaired chronically impaired brain functions even at late chronic stages.
HBOT Induces Cerebral Angiogenesis and Nerve Fiber Regeneration in Chronic TBI
Tal S, Hadanny A, Sasson E, Suzin G, Efrati S. (2017). Frontiers in Human Neuroscience
Imaging study in patients with prolonged post-concussion syndrome due to TBI. HBOT induced cerebral angiogenesis with increased perfusion to chronically damaged brain tissue, and DTI demonstrated regeneration of nerve fibers, months to years after injury. This provides the mechanistic basis (new blood vessel growth and axonal repair) for the cognitive gains reported in the TBI trials above.
Doenyas-Barak K, Catalogna M, Kutz I, et al. (2022). PLoS ONE (29 citations)
RCT in combat veterans (n=35) with treatment-resistant PTSD. 60 daily HBOT sessions produced a large-magnitude improvement in PTSD severity vs. control (CAPS-V: p<0.0001, effect size 1.64), with significant reductions in depression and symptom severity. fMRI confirmed restored activity in the prefrontal cortex, hippocampus, and insula. DTI showed increased white matter integrity in fronto-limbic tracts critical for emotional regulation.
HBOT for Veterans With Combat-Associated PTSD: A Randomized, Sham-Controlled Clinical Trial
Doenyas-Barak K, Kutz I, Lang E, et al. (2024). Journal of Clinical Psychiatry
Randomized, sham-controlled trial in male veterans with combat-associated, treatment-resistant PTSD (60 daily sessions, 90 min, 100% oxygen at 2.0 ATA vs. 1.02 ATA sham). The HBOT group showed a significant reduction in CAPS-5 total score versus sham, with benefit sustained at 3-month follow-up; a meaningful reduction in symptom load was seen in 68% of treated veterans. fMRI and DTI confirmed restored fronto-limbic activity and white matter integrity. This is the most recent and largest sham-controlled PTSD trial from the Sagol Center; Israel’s Ministry of Defense funds this treatment for qualifying veterans.
Low-Pressure HBOT for Blast-Induced Post-Concussion Syndrome and PTSD
Harch PG, Andrews SR, Fogarty EF, et al. (2012). Journal of Neurotrauma
Phase I trial in a U.S. military cohort with chronic blast-induced mild-to-moderate TBI/post-concussion syndrome and PTSD (n=16; forty 1.5 ATA, 60-minute sessions over 30 days). Produced significant improvements in symptoms, neurological exam findings, cognitive testing, and quality-of-life measures, with concomitant significant improvement on SPECT brain imaging. 64% of subjects on psychoactive or narcotic prescription medication reduced or discontinued it during the study. Directly relevant to the SOF blast-exposure population.
Effect of HBOT on Chronic Neurocognitive Deficits of Post-TBI Patients: Retrospective Analysis
Hadanny A, Abbott S, Suzin G, et al. (2018). BMJ Open (41 citations)
Largest published cohort of chronic TBI patients (n=154) across all severities, mean 4.6 years post-injury. HBOT produced significant improvement in every cognitive domain tested (p<0.00001). Memory improved by 8.1 points and attention by 6.8 points. SPECT imaging confirmed increased metabolic activity in prefrontal and temporal regions, correlating directly with clinical gains.
HBOT Improves Post-Concussion Symptoms in Adults With Childhood TBI
Shabi Shlifer A, Suzin G, Shorer R, et al. (2025). Frontiers in Neurology
Retrospective cohort (n=26) of adults with persistent post-concussion symptoms stemming from childhood TBI, treated with at least 40 HBOT sessions (90 min, 100% oxygen at 2.0 ATA with air breaks). Statistically significant improvement across all cognitive domains except motor skills, including global cognition, memory, executive function, attention, and processing speed. Patients with a history of mild TBI responded similarly to those with severe injury, and gains occurred a mean of roughly 24 years after injury, reinforcing that chronic TBI remains treatable long after the acute event.
HBOT Induces Late Neuroplasticity in Post-Stroke Patients: A Randomized, Prospective Trial
Efrati S, Fishlev G, Bechor Y, et al. (2013). PLoS ONE
Randomized, prospective crossover trial (n=74) in patients 6–36 months post-stroke with chronic neurological deficits (40 sessions, 90 min, 100% oxygen at 2.0 ATA). Neurological function and quality of life improved significantly after HBOT, with no improvement during the untreated control period; SPECT imaging correlated with clinical gains. A landmark demonstration that HBOT can reactivate neuroplasticity in viable but metabolically dormant brain tissue long after injury, the same mechanism that underlies its effect in chronic TBI.
Cognitive Enhancement of Healthy Older Adults Using Hyperbaric Oxygen: A Randomized Controlled Trial
Hadanny A, Daniel-Kotovsky M, Suzin G, et al. (2020). Aging (54 citations)
RCT (n=63 healthy adults >64 years) demonstrating cognitive benefits in a non-injured population. Three months of HBOT produced significant improvements in global cognitive function (p=0.0017), with strongest gains in attention (effect size 0.745) and information processing speed (effect size 0.788). MRI confirmed increased cerebral blood flow in frontal and parietal regions. Critically, this study demonstrates cognitive enhancement potential beyond injury recovery.
HBOT Has a Better Cognitive Outcome than NBH for Patients with Mild Traumatic Brain Injury
Liu Z, Jia Z, Shi X, et al. (2023). Medicine
Prospective RCT (Oct 2017–Mar 2023) comparing HBOT vs. normobaric hyperoxia (NBH) vs. control in mTBI patients. HBOT group achieved higher cognitive scores (MoCA and MMSE) and lower biomarkers of brain injury (S100β, NSE, GFAP) than both NBH and control groups. HBOT delivers superior cognitive recovery compared to normobaric oxygen alone.
Combined HBO2 and NBH: Phase II Clinical Trial in Severe TBI
Rockswold SB, Rockswold GL, Zaun DA, et al. (2013). Journal of Neurosurgery (148 citations)
Phase II RCT (n=42, mean GCS 5.7) in severe TBI. Combined HBOT/NBH produced a 26% absolute reduction in mortality (p=0.048) and 36% improvement in favorable outcomes on the Glasgow Outcome Scale (p=0.024). Significant improvements in oxidative cerebral metabolism and sustained reduction in intracranial pressure. No signs of oxygen toxicity.
Synthesis: Across multiple RCTs, a Naval Special Warfare-affiliated meta-analysis, and the largest retrospective cohort to date, HBOT consistently delivers clinically significant improvements in attention, memory, processing speed, and executive function following TBI. Benefits extend to healthy populations without prior injury, demonstrating cognitive optimization potential for high-performing operators. Neuroimaging consistently confirms the mechanism: increased cerebral blood flow and white matter integrity restoration.